P‐Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress. Issue 1 (7th November 2014)
- Record Type:
- Journal Article
- Title:
- P‐Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress. Issue 1 (7th November 2014)
- Main Title:
- P‐Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress
- Authors:
- Watanabe, Hiroshi
Miyamoto, Yohei
Enoki, Yuki
Ishima, Yu
Kadowaki, Daisuke
Kotani, Shunsuke
Nakajima, Makoto
Tanaka, Motoko
Matsushita, Kazutaka
Mori, Yoshitaka
Kakuta, Takatoshi
Fukagawa, Masafumi
Otagiri, Masaki
Maruyama, Toru - Abstract:
- <abstract abstract-type="main" id="prp292-abs-0001"> <title>Abstract</title> <p>The major cause of death in patients with chronic kidney disease (CKD) is cardiovascular disease. Here, <italic>p</italic>‐Cresyl sulfate (PCS), a uremic toxin, is considered to be a risk factor for cardiovascular disease in CKD. However, our understanding of the vascular toxicity induced by PCS and its mechanism is incomplete. The purpose of this study was to determine whether PCS enhances the production of reactive oxygen species (ROS) in vascular endothelial and smooth muscle cells, resulting in cytotoxicity. PCS exhibited pro‐oxidant properties in human umbilical vein endothelial cells (HUVEC) and aortic smooth muscle cells (HASMC) by enhancing NADPH oxidase expression. PCS also up‐regulates the mRNA levels and the protein secretion of monocyte chemotactic protein‐1 (MCP‐1) in HUVEC. In HASMC, PCS increased the mRNA levels of alkaline phosphatase (ALP), osteopontin (OPN), core‐binding factor alpha 1, and ALP activity. The knockdown of Nox4, a subunit of NADPH oxidase, suppressed the cell toxicity induced by PCS. The vascular damage induced by PCS was largely suppressed in the presence of probenecid, an inhibitor of organic anion transporters (OAT). In PCS‐overloaded 5/6‐nephrectomized rats, plasma MCP‐1 levels, OPN expression, and ALP activity of the aortic arch were increased, accompanied by the induction of Nox4 expression. Collectively, the vascular toxicity of PCS can be attributed to its<abstract abstract-type="main" id="prp292-abs-0001"> <title>Abstract</title> <p>The major cause of death in patients with chronic kidney disease (CKD) is cardiovascular disease. Here, <italic>p</italic>‐Cresyl sulfate (PCS), a uremic toxin, is considered to be a risk factor for cardiovascular disease in CKD. However, our understanding of the vascular toxicity induced by PCS and its mechanism is incomplete. The purpose of this study was to determine whether PCS enhances the production of reactive oxygen species (ROS) in vascular endothelial and smooth muscle cells, resulting in cytotoxicity. PCS exhibited pro‐oxidant properties in human umbilical vein endothelial cells (HUVEC) and aortic smooth muscle cells (HASMC) by enhancing NADPH oxidase expression. PCS also up‐regulates the mRNA levels and the protein secretion of monocyte chemotactic protein‐1 (MCP‐1) in HUVEC. In HASMC, PCS increased the mRNA levels of alkaline phosphatase (ALP), osteopontin (OPN), core‐binding factor alpha 1, and ALP activity. The knockdown of Nox4, a subunit of NADPH oxidase, suppressed the cell toxicity induced by PCS. The vascular damage induced by PCS was largely suppressed in the presence of probenecid, an inhibitor of organic anion transporters (OAT). In PCS‐overloaded 5/6‐nephrectomized rats, plasma MCP‐1 levels, OPN expression, and ALP activity of the aortic arch were increased, accompanied by the induction of Nox4 expression. Collectively, the vascular toxicity of PCS can be attributed to its intracellular accumulation via OAT, which results in an enhanced NADPH oxidase expression and increased ROS production. In conclusion, we found for the first time that PCS could play an important role in the development of cardiovascular disease by inducing vascular toxicity in the CKD condition.</p> </abstract> … (more)
- Is Part Of:
- Pharmacology research & perspectives. Volume 3:Issue 1(2015:Feb.)
- Journal:
- Pharmacology research & perspectives
- Issue:
- Volume 3:Issue 1(2015:Feb.)
- Issue Display:
- Volume 3, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 3
- Issue:
- 1
- Issue Sort Value:
- 2015-0003-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2014-11-07
- Subjects:
- Pharmacology -- Periodicals
Drug development -- Periodicals
615.105 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/prp2.92 ↗
- Languages:
- English
- ISSNs:
- 2052-1707
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3431.xml